- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06688526
Auditory Stimulation Effect on Brain Oscillations and Sleep Dependent Learning
June 28, 2026 updated by: Catherine Chu, MD, Massachusetts General Hospital
The investigators are testing the impact of quiet sounds played during sleep on brain oscillations and memory.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Participants will undergo two visits with a memory task and nap.
During one of the visits, quiet sounds will be played timed with sleep oscillations.
During the other visit, no sounds will be played.
Brain oscillations and memory will be measured at each visit.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Charlestown, Massachusetts, United States, 02129
- Athinoula A. Martinos Center Biomedical Imaging
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria: Adult -
Exclusion Criteria: History of neurological disease, psychiatric disease, sleep apnea or sleep disorder.
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Auditory Stimulation
Quiet sounds are played during sleep
|
Quiet sounds are played during sleep
|
|
Sham Comparator: Sham Stimulation
Volume is set to zero.
|
No sounds are played during sleep
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep spindle rate
Time Frame: 90 minutes
|
Sleep spindles are prominent thalamocortical brain oscillations seen on EEG during sleep that have been mechanistically linked to sleep-dependent memory consolidation.
The sleep spindle rate over the course of the nap will be assessed using an automated spindle detector applied to the collected EEG sleep data.
|
90 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Memory consolidation
Time Frame: 90 minutes
|
The motor sequence task (MST), a validated probe of memory consolidation, will be used to measure sleep-dependent memory consolidation.
Participants will trained on MST before the nap opportunity and tested on MST after the nap opportunity to reliably measure memory consolidation.
|
90 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Catherine Chu, MD, Massachusetts General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 13, 2024
Primary Completion (Actual)
June 30, 2025
Study Completion (Actual)
June 30, 2025
Study Registration Dates
First Submitted
October 25, 2024
First Submitted That Met QC Criteria
November 13, 2024
First Posted (Actual)
November 14, 2024
Study Record Updates
Last Update Posted (Actual)
June 30, 2026
Last Update Submitted That Met QC Criteria
June 28, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2024P002714
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Deidentified data will be shared upon request to the study PI
IPD Sharing Time Frame
within one year of study termination
IPD Sharing Access Criteria
Academic investigators
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.